| Name | Title | Contact Details |
|---|
Goodroot is a community of companies committed to reinventing healthcare one system at a time. Our mission is to reshape how our current system operates and make healthcare more affordable and more accessible for all. We develop and leverage businesses that not only improve the current state of healthcare delivery, but that also reform or replace the most critical parts of the system that are no longer working. Goodroot offers and sells the full range of products and services of all brands and companies underneath our umbrella to offer the most idealistic approach of capabilities for our clients. With a growing group of brands including RemedyOne, AlignRx, Penstock, Famulus, CoeoRx and ScholarScripts, Goodroot aims to helps everyone from pharmacy management to payment integrity and everyone in between.
SilverCloud Health is the world`s leading digital mental health company, enabling healthcare organizations to deliver clinically validated digital therapeutic care that improves outcomes, increases access and scale while reducing costs.
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Delphinus is committed to creating improved imaging methods that assist medical professionals to better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, without the concern of radiation or pain. Headquartered in Plymouth, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals. Known as SoftVue™, three critical sound characteristics are measured and refined through proprietary algorithms, advancing this technology far beyond traditional b-mode ultrasound. By collecting and defining reflection, sound speed, and attenuation data in a 360° orientation, data are gathered and reconstructed in tomographic coronal planes, providing an enriched image set presented for cross-sectional review. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography. Delphinus was formed in 2010 as a spin-out of Karmanos Cancer Institute [KCI] in Detroit, MI. Created by Peter Littrup, MD of Karmanos and Neb Duric, PhD of Wayne State University Detroit, MI the SoftVue technology presents a new imaging paradigm in breast disease assessment. Karmanos Cancer Institute has served as a primary investigational site for case collection and clinical studies. Delphinus holds numerous patents and proprietary assets for its innovative and scientifically-advanced works and is poised to usher in a new era of breast imaging.
NuWave is a Upland, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
University of Vermont - College of Medicine is a Burlington, VT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.